Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-029643
Filing Date
2021-05-03
Accepted
2021-05-03 19:59:16
Documents
1
Period of Report
2021-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3998
  Complete submission text file 0001209191-21-029643.txt   5405
Mailing Address THE JOHN HANCOCK TOWER 200 CLARENDON STREET, 54TH STREET BOSTON MA 02116
Business Address
EVNIN LUKE (Reporting) CIK: 0001134657 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40366 | Film No.: 21885369

Mailing Address 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA 02138 617-952-0555
Werewolf Therapeutics, Inc. (Issuer) CIK: 0001785530 (see all company filings)

EIN.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations